Mercedes-Benz USA, LLC
Summary
NHTSA campaign 25V129: Mercedes-Benz USA, LLC recalled for a safety defect. A loss of drive power increases the risk of a crash.
Details
Source
nhtsa
External ID
25V129
Action Date
2025-03-03
Status
Ongoing
Category
vehicle
Product Description
Mercedes-Benz USA, LLC (MBUSA) is recalling certain 2023-2024 AMG GT 63 S E Performance 4-door coupe, 2025 AMG GLC 63 S E Performance, GLC 63 S E Performance Coupe, AMG GT 63 S E Performance, 2023-2025 AMG S 63 E Performance, and 2024-2025 AMG SL 63 S E Performance vehicles with a hybrid powertrain. A software error may cause the high-voltage starter alternator control unit to fail, causing a loss of drive power.
Company
Context & Analysis
Mercedes-Benz USA, LLC has 149 FDA actions in our database.
Frequently Asked Questions
How often does Mercedes-Benz USA, LLC have FDA actions?
Mercedes-Benz USA, LLC has 149 FDA actions in our database, including 0 recalls and 0 device clearances.
Where can I find the official FDA record?
The official record is available on FDA.gov. Use the link above to view the complete official filing. You can also use the openFDA API to query this record programmatically.
Want to know the moment something like this happens?
Get alerts for vehicle